ZMYND8 and breast cancer: Transwell assay results demonstrated that under both non-Matrigel (migration) and Matrigel-coated (invasion) conditions, ZMYND8-overexpressing breast cancer cells exhibited significantly enhanced migratory and invasive capabilities (Fig. 3C).